000 02297nam a22003495i 4500
001 235604
003 ES-VaUE
005 20221220020715.0
007 cr nn 008mamaa
008 120720s2012 xxu| s |||| 0|eng d
020 _a9781617799655
024 7 _a10.1007/978-1-61779-965-5
_2doi
040 _aES-MaUEC
_bspa
_cES-MaUEC
245 1 0 _aBioinformatics and Drug Discovery
_cedited by Richard S. Larson.
250 _a2nd edition 2012
264 1 _aTotowa, NJ
_bHumana Press
_c2012
300 _a1 recurso en línea (XII, 374 páginas)
_b104 ilustraciones, 56 ilustraciones a color
336 _atexto
_btxt
_2rdacontent
337 _aelectrónico
_bc
_2rdamedia
338 _arecurso electrónico
_bcr
_2rdacarrier
347 _aarchivo de texto
_bPDF
490 0 _aMethods in Molecular Biology
_x1940-6029
_v910
520 _aRecent advances in drug discovery have been rapid.  The second edition of  Bioinformatics and Drug Discovery has been completely updated to include topics that range from new technologies in target identification, genomic analysis, cheminformatics, protein analysis, and network or pathway analysis. Each chapter provides an extended introduction that describes the theory and application of the technology. In the second part of each chapter,  detailed procedures related to the use of these technologies and software have been incorporated. Written in the highly successful Methods in Molecular Biology™ series format, the chapters include the kind of detailed description and implementation advice that is crucial for getting optimal results in the laboratory. Thorough and intuitive, Bioinformatics and Drug Discovery, Second Edition  seeks to aid scientists in the further study of the rapidly expanding field of drug discovery.
700 1 _aLarson, Richard S
_eeditor literario
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
776 0 8 _iPrinted edition:
_z9781617799648
776 0 8 _iPrinted edition:
_z9781617799662
776 0 8 _iPrinted edition:
_z9781493959297
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-1-61779-965-5
_z(usuarios Universidad Europea de Valencia)
942 _2lcc
_cLE
988 _aSpringer_Protocols_2012
999 _c235604
_d235604